The technology optimizes the microstructure of biomaterials to enable greater strength gain in resorbable implantables. It offers a platform upon which to develop next generation resorbable orthopedic products.
Proxy Biomedical is a company that focuses on biomaterial solutions for medical implantable products.
More articles on devices:
Smith & Nephew shares lost 7.14% last week — 5 key updates
Stryker shares drop 4.94% in 7 days: 5 things to know
Minimus Spine receives U.S. patent — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
